10月21日，直觉外科夜盘下跌6.85%，报408.0美元/股。
消息面上，公司三季度调整后每股收益3.00美元、营收30.49亿美元，均高于市场预期，但管理层收紧了机器人手术量增长展望，预计全球达芬奇手术量增速将更接近14%至15%区间中点。
从结构看，三季度美国达芬奇手术量增长10%，美国以外地区增长20%。由于美国业务约占公司总量六成，且此前管理层已提示美国业务放缓、平价医疗法案加强版补贴到期对美国手术量有轻微负面影响，市场对增长持续性的关注压过了当季业绩超预期。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.